Abstract
Phospho-specific antibody technology has been recently adopted to study p53 phosphorylation both in vivo and in vitro. We have developed and carefully characterized p53 phospho-specific reagents directed to major amino- and carboxy-terminal regulatory sites. The specificities of both polyclonal and monoclonal reagents targeting the same phospho-epitope are discussed. We have defined the major chemical binding determinants for specific monoclonal reagents by determining the relative contribution of charge and sequence to epitope recognition. Remarkably, we have found that the utility of these reagents in different assay systems is not universal and depends both on epitope conformation and affinity. This is reflected in the striking differences in their ability to detect endogenous p53 and recombinant protein. Therefore, we conclude that this novel class of reagents is not generally applicable, but that the utility of each reagent must be determined empirically.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vogelstein, B., Lane, D. P., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307–310.
Hupp, T. R., Lane, D. P., and Ball, K. L. (2000) Strategies for manipulating the p53 pathway in the treatment of human cancer. Biochem. J. 352, 1–17.
Hupp, T. R., Sparks, A., and Lane, D. P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237–245.
Blaydes, J. P. and Hupp, T. R. (1998) DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site. Oncogene 17, 1045–1052.
Wang, Y. and Prives, C. (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376, 88–91.
Blaydes, J. P., Luciani, M. G., Pospisilova, S., Ball, H. M., Vojtesek, B., and Hupp, T. R. (2001) Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription. J. Biol. Chem. 276, 4699–4708.
Gu, W. and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595–606.
Sakaguchi, K., Herrera, J. E., Saito, S., et al. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831–2841.
Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., and Kelly, K. (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175–1184.
Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237–1245.
Craig, A. L., Burch, L., Vojtesek, B., Mikutowska, J., Thompson, A., and Hupp, T. R. (1999) Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem. J. 342, 133–141.
Dornan, D., and Hupp, T. R. (2001) Inhibition of p53-dependent transcription by BOX-1 phospho-peptide mimetics that bind to p300. EMBO Rep. 2, 139–144.
Yeargin, J. and Haas, M. (1995) Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest. Curr. Biol. 5, 423–431.
Bond, J. A., Webley, K., Wyllie, F. S., Jones, C. J., Craig, A., Hupp, T., and Wynford-Thomas, D. (1999) p53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts. Oncogene 18, 3788–3792.
Abraham, J., Spaner, D., and Benchimol, S. (1999) Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells. Oncogene 18, 1521–1527.
Craig, A. L., Blaydes, J. P., Burch, L. R., Thompson, A. M., and Hupp, T. R. (1999) Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation. Oncogene 18, 6305–6312.
Blaydes, J. P., Craig, A. L., Wallace, M., et al. (2000) Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways. Oncogene 19, 3829–3839.
Webley, K., Bond, J. A., Jones, C. J., Blaydes, J. P., Craig, A., Hupp, T., and Wynford-Thomas, D. (2000) Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell. Biol. 20, 2803–2808.
Atherton, E., Bridgen, J., and Sheppard, R. C. (1976) A polyamide support for solid-phase protein sequencing. FEBS Lett. 64, 173–175.
Khalkhali-Ellis, Z. (1995) An improved SDS-polyacrylamide gel electrophoresis for resolution of peptides in the range of 3.5-200kDa. Prep. Biochem. 25, 1–9.
Harlow, E. and Lane, D. P. (1988) Antibodies: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Kohler, G., Howe, S. C., and Milstein, C. (1976) Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur. J. Immunol. 6, 292–295.
Shieh, S. Y., Ahn, J., Tamai, K., Taya, Y., and Prives, C. (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289–300.
Luciani, M. G., Hutchins, J. R., Zheleva, D., and Hupp, T. R. (2000) The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A. J. Mol. Biol. 300, 503–518.
Hupp, T. R. and Lane, D. P. (1994) Allosteric activation of latent p53 tetramers. Curr. Biol. 4, 865–875.
Shieh, S. Y., Taya, Y., and Prives, C. (1999) DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18, 1815–1823.
Wallace, M., Coates, P. J., Wright, E. G., and Ball, K. L. (2001) Differential posttranslational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo. Oncogene 20, 3597–3608.
Kapoor, M., and Lozano, G. (1998) Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc. Natl. Acad. Sci. USA 95, 2834–2837.
Lu, H., Taya, Y., Ikeda, M., and Levine, A. J. (1998) Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc. Natl. Acad. Sci. USA 95, 6399–6402.
Achari, Y. and Lees-Miller, S. P. (2000) Detection of DNA-dependent protein kinase in extracts from human and rodent cells. Methods Mol. Biol. 99, 85–97.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Craig, A.L., Bray, S.E., Finlan, L.E., Kernohan, N.M., Hupp, T.R. (2003). Signaling to p53. In: Deb, S., Deb, S.P. (eds) p53 Protocols. Methods in Molecular Biology, vol 234. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-408-5:171
Download citation
DOI: https://doi.org/10.1385/1-59259-408-5:171
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-1-58829-106-6
Online ISBN: 978-1-59259-408-5
eBook Packages: Springer Protocols